Octylcyanoacrylate

Drug Profile

Octylcyanoacrylate

Alternative Names: Dermabond

Latest Information Update: 13 Jun 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Closure Medical Corporation
  • Developer Closure Medical Corporation; Ethicon
  • Class Adhesives; Cyanoacrylates; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Wounds

Most Recent Events

  • 13 Jun 2005 Closure Medical Corporation has been acquired by Johnson and Johnson
  • 18 Jan 2002 The US FDA approved amended labelling for Dermabond Adhesive incorporating its efficacy in antimicrobial protection
  • 16 Feb 2000 Registered for Wounds in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top